Understanding how these therapies work, their clinical evidence, dosing requirements, and NHS eligibility criteria is essential for patients and healthcare professionals optimising metabolic health outcomes
Vitamin B2 intake reduces the risk for colorectal cancer: a doseresponse analysis
Clinical experience is positive and the procedure has become widely adopted, but the evidence base is smaller than for micro fat
For example, studies have shown that participants taking tirzepatide (available as Mounjaro and Zepbound, or through our Compounded Tirzepatide and Oral Tirzepatide programs) can experience substantial body weight reductions, often exceeding 15-20% over prolonged treatment periods, which is more significant than with GLP-1 monotherapy alone
Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin 1-FAK signaling pathway
First, we selected candidate residues for the potential glutathione activator site and the glutathione-scaffold site
